期刊文献+

艾滋病患者深部真菌感染菌群分布及其耐药性 被引量:9

Species and drug-resistance of fungi causing deep infections in AID patients
在线阅读 下载PDF
导出
摘要 目的探讨医院住院艾滋病患者深部真菌感染的病原菌特性及其对常用抗真菌药物的敏感度,为临床治疗选用药物提供参考依据。方法采用Bact/ALERT 3D120血培养仪进行真菌培养和检测。根据菌落生长特征,用YBC鉴定卡进行菌种的鉴定与分析;ATB FUNGUS 3试条进行真菌临床敏感性测定。结果从2868份不同标本中培养分离出208株深部真菌,不同阳性标本分离菌株构成比依次为:痰34.13%(71株),脑脊液27.40%(57株),血12,50%(26株),粪10.10%(21株),骨髓7.21%(15株),尿4.81%(10株),其他部位标本3.85%(8株)。14例危重患者在多部位分离出2~3种不同种类真菌。208株真菌中,构成比居前5位者分别为:新生隐球菌34.13%(71株),白假丝酵母菌33.65%(70株),马内菲青霉菌14.90%(31株),光滑假丝酵母菌5.77%(12株),热带假丝酵母菌3.85%(8株)。新生隐球菌、白假丝酵母菌对两性霉素B及5氟胞嘧啶非常敏感(敏感率90.63%~100.00%);白假丝酵母菌、光滑假丝酵母菌及热带假丝酵母菌对氟康唑与伏立康唑显示45.45%~57.82%的耐药。马内菲青霉菌对两性霉素B及伊曲康唑敏感,敏感率分别为95.80%、84.10%。结论艾滋病患者深部真菌感染病原菌较正常人群分布特殊,加强艾滋病患者不同部位病原标本的送检及监测,对临床合理使用抗真菌药物,减少耐药真菌的产生有特别意义。 Objective To explore the characteristics and drug sensitivity of fungi causing deep fungal infections in AIDS patients, so as to provide evidence for clinical choice of drugs. Methods Fungi were cultured and tested by Bact /ALERT 3D120 blood culture system, and were identified and analyzed by Yeast Biochemical Card (YBC card) according the colony growth characteristics; sensitivity of fungi to antifungal drugs were detected by ATB FUNGUS 3 strip. Results Two hundred and eight fungal strains were isolated from 2 868 different specimens, the constituent ratios of fungi positive specimens were as follows: sputum 34. 13% (71 isolates), cerebrospinal fluid 27.40% (57 isolates), blood 12.50% (26 isolates), excrement 10.10% (21 isolates), bone marrow 7. 21%/00 (15 isolates), urine 4. 81 % (10 isolates), and the other sites 3.85% (8 isolates). Fourteen critically ill patients were isolated 2-3 different strains from multiple sits. Among all isolates, the top five constituent ratios were Cryptococcus neoformans 34. 13%(71 isolates), Candida albicans 33. 65% (70 isolates), Penicillium marneffei 14. 90% (31 isolates), Candida glahrata 5. 77%(12 isolates), and Candida tropicalis 3. 85% (8 isolates). Cryptococcus neoformans and Candida albicans were highly sensitive to amphotericin B and 5 fluorocytosin (sensitive rate was 90. 63% - 100. 00%); 45. 45% 57. 82% of Candida albicans, Candida glabrata and Candida tropicalis were resistant to fluconazole and voriconazole. Penicillium marne ffei was sensitive to amphotericin B and itraconazole, sensitive rate was 95. 80% and 84. 11 % respectively. Conclusion Deep fungal infection is specially distributed among AIDS patients. In order to use anti fungal drugs rationally and reduce the emergence of resistant strains, it is important to strengthen the detection and surveillance of pathogens from samples at different sites of AIDS patients.
出处 《中国感染控制杂志》 CAS 2011年第5期351-353,356,共4页 Chinese Journal of Infection Control
基金 十一五科技重大专项"艾滋病和病毒性肝炎等重大传染病防治"(2008ZX10001-008)
关键词 艾滋病 真菌感染 抗药性 微生物 医院感染 抗真菌药物 acquired immunodeficiency syndrome fungal infection drug resistance,microbial nosocomial infection antifungal agent
  • 相关文献

参考文献6

  • 1李丁,张文芳,郑珊,张鹏.肿瘤患者真菌感染的菌株分布及耐药性分析[J].中华医院感染学杂志,2009,19(17):2355-2357. 被引量:15
  • 2孟祥红,董梅,孙红宁,孙敏霞,杨彩娥,雷红,何菊芳,佟爱华,宋海燕.328株念珠菌菌种分布及耐药性分析[J].中国真菌学杂志,2009,4(5):288-290. 被引量:14
  • 3Sanglard D,Ischer F,Parkkinson T,et al.Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents[J].Antimicrob Agents Chemother,2003,47(8):2404-2412.
  • 4Wolfger H,Mamnum Y M,Kuckler K,et al.Fungal ABC proteins:pleiotropic drug resistance,stress response and cellular detoxification[J].Res Microbiol,2001,152(3-4):375-389.
  • 5Harry J B,Oliver B G,Song J L,et al.Drug-induced regulation of the MDR1 promoter in Candida albicans[J].Antimicrob Agents Chemother,2005,49(7):2785-2792.
  • 6Coste A T,Karababa M,Ischer F,et al.TACI,transcriptional activator of CDR genes,is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2[J].Eukaryot Cell,2004,3(6):1639-1652.

二级参考文献13

共引文献26

同被引文献88

  • 1姜拥军,尚红,张子宁,耿文清,刁莹莹,代娣,韩晓旭,张旻,王亚男,刘静,王树祥,苏艳丽,王琪.中国HIV/AIDS患者NK细胞及NKT细胞变化的检测[J].中华微生物学和免疫学杂志,2005,25(1):52-55. 被引量:15
  • 2沈银忠,卢洪洲,张永信.HIV/AIDS合并深部真菌感染[J].中国艾滋病性病,2006,12(4):379-381. 被引量:21
  • 3Vu Hai V, Ngo AT, Ngo VH, et al. Penicilliosis in vietnam:a series of 94 patient[ J]. Rev Med Interne,2010,31 (12) :812,818.
  • 4Vanittanakom N, Cooper JR, Fisher MC, et al. Penicillium Marneffei Infection and Recent Advances in the Epidemiology and Molecular biology Aspects [J]. Clin Microbiol Rev, 2006,19( 1 ) :95 - 110.
  • 5Wu TC, Chan JW, Ng CK, et al. Clinical presentations and outcomes of PeniciUium Marneffei infections: a series from 1994 to 2004 [ J ]. Hong Kong Med J,2008,4(2) : 103 -109.
  • 6Manosuthi W, Chaovavanich A, Tansuphaswadikul S, et al. Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting[J].J Infect ,2007,55 (5) :464 - 469.
  • 7Qin Y, Li Y, Liu W, et al. Penicillium Marneffei-Stimulated Dendritic Cells Enhance HIV-1 Trans-Infection and Promote Viral Infection by Activating Primary CD4 + T Cells [ J]. PLoS One,2011,6 (11) :1 -10.
  • 8Zhu L, Huang R, Guo H, et al. Cryptococcal meningitis : de- scription of 3 cases and estimation of T-cell subsets [ J ]. In- dian journal of pediatrics,2014,81 (6) :536 - 540.
  • 9Tan DB, Yong YK, Tan HY, et al. Immunological profiles of immune restoration disease presenting as myeobaeterial lym- phadenitis and cryptococcal meningitis [ J ]. HIV medicine, 2008,9(5) :307 -316.
  • 10Collazos J. Opportunistic infections of the CNS in patients with AIDS : diagnosis and management [ J ]. CNS Drugs, 2003,17 (12) :869 - 887.

引证文献9

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部